-
Product Insights
NewLikelihood of Approval Analysis for Malignant Fibrous Histiocytoma
Overview How likely is it that the drugs in Malignant Fibrous Histiocytoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Fibrous Histiocytoma Overview Malignant fibrous histiocytoma, now termed undifferentiated pleomorphic...
-
Product Insights
Ultrasound Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ultrasound Systems Pipeline Market Report Overview Ultrasound Systems are devices that make use of sound waves of high frequency to produce images of structures inside the body. Most of the devices use Sonar principles and are placed outside while in a few cases, they are even placed inside of the body. 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D Ultrasound Systems, and Hand Held Ultrasound (HHU) Systems are tracked under this category. The Ultrasound Systems pipeline market research report provides...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenal Gland Disorders
Overview How likely is it that the drugs in Adrenal Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenal Gland Disorders Overview Adrenal gland disorders comprise various conditions impacting...
-
Sector Analysis
Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Nuclear Imaging Systems Market Report Overview The nuclear imaging systems market size was valued at $1.07 billion in 2023. The nuclear imaging systems market will grow at a CAGR of more than 2% from 2023 to 2033. Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases, including cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases. Nuclear Imaging Systems Market Outlook 2023-2033 ($ Billion) Buy the Full Report...
-
Sector Analysis
C-Arms Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
C-Arms Market Insights The C-Arms market size was estimated at $1.92 billion in 2023 and is forecast to grow at a CAGR of more than 3% during 2023 and 2033. C-Arm fluoroscopic X-ray systems are used in various diagnostic imaging and minimally invasive surgical procedures. In the operating room (OR), they help visualize procedures for vascular, cardiology, orthopedic, and other therapeutic areas. C-Arms have become increasingly popular due to their wide range of utility. C-Arms Market Outlook 2023-2033 ($ Billion)...
-
Sector Analysis
Computed Tomography (CT) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Computed Tomography (CT) Systems Market Report Overview The computed tomography (CT) systems market size was $5.63 billion in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Computed tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. This technique is used in patients with a high risk of colon cancer. CT is also performed for full-motion heart scans...
-
Sector Analysis
Magnetic Resonance Imaging (MRI) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Magnetic Resonance Imaging (MRI) Systems Market Report Overview The magnetic resonance imaging (MRI) systems market size was valued at $5.21 billion in 2023 and is forecast to grow at a CAGR of over 6% during the forecast period. MRI systems are non-invasive diagnostic imaging system that utilizes strong magnetic fields. It aids in the detection & diagnosis of various conditions and the assessment of the patient's progress. MRI is useful for examinations of soft tissues & nervous system. Magnetic Resonance...
-
Sector Analysis
Contrast Media Injectors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Contrast Media Injectors Market Insights The Contrast Media Injectors (CMI) market size was estimated at $1.60 billion in 2023 and is forecast to grow at a CAGR of more than 4% during 2023 and 2033. Contrast media injectors (CMI) are injectors used in radiology to inject contrast media agents into the bloodstream of patients for the clear visualization of various medical conditions and pathologies. These injectors are used in hospitals with X-rays, computed tomography (CT), magnetic resonance imaging (MRI), Angiography...
-
Sector Analysis
Contrast Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Contrast Agents Market Report Overview The contrast agents market size was valued at $3.57 billion in 2023. The contrast agents market will grow at a CAGR of more than 2% from 2023 to 2033. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computed tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among other modalities. Contrast Agents Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More...
-
Sector Analysis
Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Nuclear Imaging Equipment Market Report Overview The nuclear imaging equipment market size was valued at $2.90 billion in 2023 and is expected to grow at a CAGR of more than 7% during 2023 and 2033. Nuclear imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases. Nuclear Imaging Equipment Market Outlook 2023-2033 ($ Billion) Buy The Full Report...